News
Mediante la modificación de un gen, los científicos esperan eliminar el colesterol alto de por vida
Summary by The El Paso Editorial Desk CNN Newsource , as published by KVIA ABC-7
· August 28, 2026
· 1 min read
Photo: KVIA ABC-7 · view original
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Byline on source page CNN Newsource, as published by KVIA ABC-7 Original story Read at the source Source published Aug 28, 2026 Indexed here Aug 29, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points The study, published in The New England Journal of Medicine, involved 15 patients with dangerously high cholesterol levels who did not respond to medication. The treatment, which involved modifying a key gene using CRISPR-Cas9, reduced cholesterol by approximately 50% for a year without adverse effects in four patients.
Scientists reported a significant reduction in artery-clogging cholesterol following a genetic modification. The treatment, which involved modifying a key gene using CRISPR-Cas9, reduced cholesterol by approximately 50% for a year without adverse effects in four patients. These patients received the highest dose of the experimental treatment as part of a pilot study.
The study, published in The New England Journal of Medicine, involved 15 patients with dangerously high cholesterol levels who did not respond to medication. The goal of the research was to evaluate the safety of five different doses of a genetic modification infusion.
Further details on the study and its findings are available from the original source, which provides more information on this experimental treatment.
More News Today’s briefing Local events
Why this story is here
KVIA ABC-7 reported and published this story. The El Paso selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by KVIA ABC-7 . The El Paso selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KVIA ABC-7 . Have a tip or correction? Contact the editor .
Category: News Published: August 28, 2026 Source: KVIA ABC-7 Reading time: 1 min
Frequently asked about this story
What is this story about? Scientists reported a significant reduction in artery-clogging cholesterol following a genetic modification. The treatment, which involved modifying a key gene using CRISPR-Cas9, reduced cholesterol…
When was this published? This article was first published on August 28, 2026 by KVIA ABC-7 and curated for The El Paso readers.
Who reported this story? This story was reported by CNN Newsource at KVIA ABC-7. To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
